irritable bowel syndrome. irritable colon
Conditions
Interventions
Intervention 1: itervention group recieved Bio Gaia once daily for one month. Intervention 2: Control group received placebo once daily for one month.
Treatment - Drugs
itervention group recieved Bio Gaia once daily for one month
Control group received placebo once daily for one month
Sponsors
Digestive and liver disase resaech center of shariati hospital
DAYA TEB co
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. having irritable bowel syndrome; 2. Not having bloating as a dominant symptom so that having bloating in 25% of the time in the last 6 months. 3. having the score of 25 in the vas100 scale for bloating; 4. agree to participate in the trial and sign the consent. Exclusion criteria: 1.age of onset above 50; 2. progressive coarse; 3. opium consumption; 4.pregnancy and lactation; 5.consumption of antimotility drugs anti diarrhea symbiotics other probiotics and antibiotics in last 2 weeks; 6.alzheimer`s or other sever psychiatric diseases; 7.inflamatory bowel disease; 8..imunodeficiency; 9..intolerance to probiotics; 7.non coperation in the trial.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bloating. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on vas100 score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal pain. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire.;Urgency. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire and vas 100 scre.;Frequency of defication. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire.;Shape of stool. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire.;Evacuation quality. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire.;Incomplete evacuation. Timepoint: one week before treatment and two weeks after treatment. Method of measurement: based on questionnaire.;Drug side effects. Timepoint: two weeks after treatment. Method of measurement: based on questionnaire.;Satisfaction from the treatment. Timepoint: two weeks after treatment. Method of measurement: based on questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Albaji Maryam
Tehran university of medical science
Outcome results
None listed